期刊文献+

高血压合并糖尿病患者降压用药情况调查分析 被引量:3

Investigation and analysis of diabetic hypertensive patients taking antihypertensive drugs
下载PDF
导出
摘要 目的:了解高血压合并糖尿病患者的用药现状,分析其降压药物使用情况,为合理治疗提供依据。方法:将入选病例分为观察组(高血压合并糖尿病)和对照组(未合并糖尿病),回顾性调查两组患者降压药物使用情况,包括降压药的使用种类、频率及联合用药情况。结果:观察组降压治疗方案中使用较多的是血管紧张素转换酶抑制剂(A-CEI)和血管紧张素Ⅱ受体阻断药(ARB),其平均服用降压药物种类要显著多于对照组(P<0.05)。结论:对于合并糖尿病的高血压患者,应综合分析其危险水平、降压疗效、对临床终点事件的影响、治疗的依从性和安全性及经济状况等,构建合理的治疗方案。 Objective:To investigate the drug use situation of diabetic hypertensive patients and analyze their use of antihy- pertensive drugs, to bring gist for reasonable treat. Methods: The selected patients were divided into observation group(dia-betic hypertensive patients) and control group (no diabetes).To investigate their use of antihypertensive drugs retrospectively, including kind, frequency and unit used condition. Results: ACEI and ARB were frequently used in the treatment scheme of observation group, whose kind of antihypertensive drugs were obviously more than control group(P〈0.05). Condusion: In order to set up reasonable treatment scheme of diabetic hypertensive patients, we should comprehensively analyze their risk level, antihypertensive effect, the influence to clinical terminal event, compliance, safe and economic situation.
作者 徐宜江
出处 《中国医药导报》 CAS 2008年第16期119-120,共2页 China Medical Herald
关键词 糖尿病 高血压 药物利用 Diabetes Hypertension Drug utilization
  • 相关文献

参考文献3

二级参考文献14

  • 1Russell C,Dunbar P,Salisbury S,et al.Hypertension control:results from the Diabetes Care Program of Nova Scotia registry and impact of changing clinical practice guidelines.Cardiovas Diabetol,2005,4:11.
  • 2Brenner BM.AMGEN International Prize:the history and future of renoprotection.Kidney Int,2003,64:1163-1168.
  • 3Barnett AH.Preventing renal complications in diabetic patients:the diabetics exposed to telmisartan and enalapril (DETAIL) study.Acta Diabetol,2005,42:S42-S49.
  • 4Whelton PK,Barzilay J,Cushman WC,et al.Clinical outcomes in antihypertensive treatment of type 2 diabetes,impaired fasting glucose concentration,and normoglycemia:Antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT).Arch Intern Med,2005,165:1401-1409.
  • 5Abuissa H,Jones PG,Marso SP,et al.Angiotensin converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes.J Am Coll Cardiol,2005,46:821-826.
  • 6Taylor EN,Hu FB,Curhan GC.Antihypertensive medications and the risk of incident type 2 diabetes.Diabetes Care,2006,29:1065-1070.
  • 7American Diabetes Association.Standards of medical care in diabetes.Diabetes Care,2004,27(suppl 1):s15-s35.
  • 8Johnson ML,Singh H.Patterns of antihypertensive therapy among patients with diabetes.J Gen Intern Med,2005,20:842-846.
  • 9Mason JM,Dickinson HO,Nicolson DJ.The diabetogenic potential of thiazide-type diuretic and beta-blocker combinations in patients with hypertension.J Hypertens,2005,23:1777-1781.
  • 10Izzedine H,Launay-Vacher V,Deybach C,et al.Drug-induced diabetes mellitus.Expert Opin Drug Saf,2005,4:1097-1109.

共引文献64

同被引文献15

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部